Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy ; volume:04 ; number:03 ; year:2022 ; pages:e197-e206
Pharmaceutical fronts ; 04, Heft 03 (2022), e197-e206
- Beteiligte Personen und Organisationen
-
Duan, Yu-Hang
Bian, Yan-lin
Zhu, Jian-Wei
- DOI
-
10.1055/s-0042-1755454
- URN
-
urn:nbn:de:101:1-2022120111450188422056
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Duan, Yu-Hang
- Bian, Yan-lin
- Zhu, Jian-Wei
Ähnliche Objekte (12)
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Establishment of anti-mesothelioma monoclonal antibodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease